Comparison 7. Nd:YAG laser versus oral propranolol.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Clearance | 1 | 65 | Risk Ratio (M‐H, Random, 95% CI) | 2.57 [0.28, 23.44] |
2 Adverse events: hyperpigmentation | 1 | 65 | Risk Ratio (M‐H, Random, 95% CI) | 2.57 [0.28, 23.44] |
3 Adverse event: pigmentation and thinning | 1 | 40 | Risk Ratio (M‐H, Random, 95% CI) | 0.33 [0.11, 1.05] |
4 Adverse events: superficial scar | 2 | 105 | Risk Ratio (M‐H, Random, 95% CI) | 1.52 [0.24, 9.58] |
5 Other measures of resolution: excellent response | 1 | 40 | Risk Ratio (M‐H, Random, 95% CI) | 0.33 [0.08, 1.46] |